Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Zupancic

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
STAR Protocols|January 31, 2022
Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesisJennifer M Zupancic, Alec A Desai, Peter M Tessier
Methods in Molecular Biology (Clifton, N.J.)|April 28, 2022
Isolating Anti-amyloid Antibodies from Yeast-Displayed LibrariesAlec A Desai, Jennifer M Zupancic, Matthew D Smith, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 14, 2017
Protein Adsorption to Charged Gold Nanospheres as a Function of Protein DeformabilityJordan M Dennison, Jennifer M Zupancic, Wayne Lin, et al.
Protein Science : a Publication of the Protein Society|May 9, 2024
Native ion mobility-mass spectrometry reveals the binding mechanisms of anti-amyloid therapeutic antibodiesYilin Han, Alec A Desai, Jennifer M Zupancic, et al.
Frontiers in Immunology|April 16, 2026
Discovering novel therapeutic V<sub>H</sub>Hs for emerging viruses: perspectives from VEEV selection strategiesAutumn T LaPointe, Fortunato Ferrara, Jennifer M Zupancic, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Discovering Novel Therapeutic V <sub>H</sub> Hs for Emerging Viruses: Perspectives from VEEV Selection StrategiesAutumn T LaPointe, Fortunato Ferrara, Jennifer M Zupancic, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGsGhasidit Pornnoppadol, Layne G Bond, Michael J Lucas, et al.
Cell Chemical Biology|October 27, 2023
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGsGhasidit Pornnoppadol, Layne G Bond, Michael J Lucas, et al.
Nature Biomedical Engineering|September 4, 2023
Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learningEmily K Makowski, Tiexin Wang, Jennifer M Zupancic, et al.
Advanced Therapeutics|September 13, 2021
Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 VariantsJennifer M Zupancic, John S Schardt, Alec A Desai, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
STAR Protocols|January 31, 2022
Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesisJennifer M Zupancic, Alec A Desai, Peter M Tessier
Methods in Molecular Biology (Clifton, N.J.)|April 28, 2022
Isolating Anti-amyloid Antibodies from Yeast-Displayed LibrariesAlec A Desai, Jennifer M Zupancic, Matthew D Smith, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 14, 2017
Protein Adsorption to Charged Gold Nanospheres as a Function of Protein DeformabilityJordan M Dennison, Jennifer M Zupancic, Wayne Lin, et al.
Protein Science : a Publication of the Protein Society|May 9, 2024
Native ion mobility-mass spectrometry reveals the binding mechanisms of anti-amyloid therapeutic antibodiesYilin Han, Alec A Desai, Jennifer M Zupancic, et al.
Frontiers in Immunology|April 16, 2026
Discovering novel therapeutic V<sub>H</sub>Hs for emerging viruses: perspectives from VEEV selection strategiesAutumn T LaPointe, Fortunato Ferrara, Jennifer M Zupancic, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Discovering Novel Therapeutic V <sub>H</sub> Hs for Emerging Viruses: Perspectives from VEEV Selection StrategiesAutumn T LaPointe, Fortunato Ferrara, Jennifer M Zupancic, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGsGhasidit Pornnoppadol, Layne G Bond, Michael J Lucas, et al.
Cell Chemical Biology|October 27, 2023
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGsGhasidit Pornnoppadol, Layne G Bond, Michael J Lucas, et al.
Nature Biomedical Engineering|September 4, 2023
Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learningEmily K Makowski, Tiexin Wang, Jennifer M Zupancic, et al.
Advanced Therapeutics|September 13, 2021
Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 VariantsJennifer M Zupancic, John S Schardt, Alec A Desai, et al.
Pageof 2